Jean-Pierre Sommadossi, President, CEO, and Chairman: Atea Pharmaceuticals AVIR Sell · Filed 24/09/19

Trade details

Type: Insider sale
Amount: $137,461.05
Shares · price: 33,941 sh · $4.05 a share
Held after: 5,890,053 sh
Stock: Atea Pharmaceuticals AVIR
Person: Jean-Pierre SommadossiPresident, CEO, and Chairman
Trade date: 24/09/17
Filed: 24/09/19
Days to filing: 2 days

Sold 0.6% of holdings

Share of holding sold: 0.6%

Atea Pharmaceuticals trades, last 26 weeks

What else happened in Atea Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/18~24/10/17

Jean-Pierre Sommadossi's recent trades

Jean-Pierre SommadossiPresident, CEO, and Chairman
Sell10b5-1 planAtea Pharmaceuticals
Sell10b5-1 plan
Atea Pharmaceuticals
AVIR
$89.4K
22,187 sh
$89.4K
Filed 24/09/19
Traded 24/09/18
Jean-Pierre SommadossiPresident, CEO, and Chairman
Sell10b5-1 planAtea Pharmaceuticals
Sell10b5-1 plan
Atea Pharmaceuticals
AVIR
$7,364
1,841 sh
$7,364
Filed 24/09/19
Traded 24/09/19
Jean-Pierre SommadossiPresident, CEO, and Chairman
Sell10b5-1 planAtea Pharmaceuticals
Sell10b5-1 plan
Atea Pharmaceuticals
AVIR
$4,024
1,006 sh
$4,024
Filed 24/06/07
Traded 24/06/05
Jean-Pierre SommadossiPresident, CEO, and Chairman
Sell10b5-1 planAtea Pharmaceuticals
Sell10b5-1 plan
Atea Pharmaceuticals
AVIR
$219.1K
56,910 sh
$219.1K
Filed 24/02/02
Traded 24/02/01

Jean-Pierre Sommadossi, Chairman — sold $137.5K of Atea Pharmaceuticals AVIR · 0.6% of holdings · 10b5-1 plan | Whalegun